Surveillance For New Lung Primaries

Stopped early

Conditions studied: Lung Cancer

In brief

The primary goal of this study is to determine the prevalence of tracheobronchial carcinomas in patients with a history of squamous cell cancer of the aerodigestive tract who have been treated with a curative intent and remain disease free. Detection of pre-invasive and invasive lesions (moderate to severe dysplasia, CIS) with fluorescence bronchoscopic surveillance may help to define the natural history of these lesions and allow earlier intervention should they progress to invasive lesions.

Key facts

Study ID

NCT00205439

Run by

University of Wisconsin, Madison

People needed

200

Starts

2001-12-01

Expected to finish

2005-12-01

Last updated by the study team

2019-11-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History squamous cell NSCLC who have undergone complete resection or definitive chemotherapy

You may not qualify if…

• History of an aerodigestive tract carcinoma of non-squamous histology
• Patients who have Stage IIIA, IIIB or IV squamous cell lung cancer that have undergone resection or chemotherapy within three years
• Patients who have Stage I or II squamous cell lung cancer that have undergone resection or chemotherapy within one year
• Patients who have received external beam radiation therapy for treatment of a squamous cell cancer of the lung

Where it is running

• University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.